The International Myeloma Society and Paula and Rodger Riney Foundation offer the 2027 Translational Research Award to advance the prevention, early detection, diagnosis, and treatment of plasma cell disorders. The program supports investigator-initiated research with clinical potential, including novel therapies, biomarkers, imaging, and molecular approaches.
Eligibility Criteria
- Established faculty researchers or scientists holding an MD and/or PhD.
- Researchers entering myeloma research from other fields are encouraged.
- The principal investigator or co-investigator must be an IMS member.
- Projects must demonstrate a clear translational endpoint relevant to myeloma.
- Previous recipients cannot apply with a different research proposal.
Funding Details
- Amount: $175,000–$250,000, including up to 8% institutional overhead.
- Duration: One year initially; second-year funding requires substantial progress and available funding.
- Supports salaries, laboratory supplies, services, and travel.
- Equipment requires specific justification of its essential need.
Deadline
- Application: January 29, 2027, at 11:59 PM EST.